Acadia (ACAD) Begins Study on ACP-101 for Hyperphagia in PWS
https://www.zacks.com/stock/news/2192107/acadia-acad-begins-study-on-acp-101-for-hyperphagia-in-pws?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2192107
Dec 01, 2023 - Acadia (ACAD) begins late-stage development of carbetocin nasal spray for the treatment of hyperphagia in Prader-Willi syndrome.
0
Pages: 12
<Page 2